- Genor Biopharma Co. Ltd is a biopharmaceutical powerhouse focusing on developing and commercializing oncology and autoimmune drugs.
- We have successfully developed drug candidates targeting pathways with blockbuster potentials, encompassing top three oncology targets and five out of the ten bestselling drugs globally.
- We have leveraged primarily in-house capabilities in establishing a pipeline of 15 targeted drug candidates with tremendous commercialization potentials in China that cover both proven and novel biological pathways.


Latest News
-
2025-01-20The research data of Lerociclib(GB491) was published on Nature Communications, Genor Biopharma’s highly selective oral CDK4/6 inhibitor again recognized at globe
-
2024-09-14Genor Biopharma presents the safety and efficacy results of GB263T at 2024 ESMO
-
2024-08-28Genor Biopharma Releases Its Interim Results for 2023
Find Out More